Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Gains from Investment Securities (2020 - 2025)

Insight Molecular Diagnostics (IMDX) has disclosed Gains from Investment Securities for 6 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Dec 2025, down 51.82% year-over-year, with the annual reading at $1.3 million for FY2025, 27.43% up from the prior year.
  • Gains from Investment Securities hit -$1.1 million in Q4 2025 for Insight Molecular Diagnostics, down from $27000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $25.0 million in Q4 2021 to a low of -$18.3 million in Q1 2023.
  • Historically, Gains from Investment Securities has averaged $1.9 million across 5 years, with a median of $177808.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: soared 3218.18% in 2021 and later crashed 21296.67% in 2022.
  • Year by year, Gains from Investment Securities stood at $25.0 million in 2021, then tumbled by 30.97% to $17.3 million in 2022, then tumbled by 35.2% to $11.2 million in 2023, then crashed by 36.16% to $7.1 million in 2024, then tumbled by 115.62% to -$1.1 million in 2025.
  • Business Quant data shows Gains from Investment Securities for IMDX at -$1.1 million in Q4 2025, $27000.0 in Q3 2025, and $2.8 million in Q2 2025.